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Background: The 19-kDa C-terminal region of the merozoite surface protein-1 of the human malaria parasite
Plasmodium falciparum (PfMSP-119) constitutes the major component on the surface of merozoites and is considered
as one of the leading candidates for asexual blood stage vaccines. Because the protein exhibits a level of sequence
variation that may compromise the effectiveness of a vaccine, the global sequence diversity of PfMSP-119 has been
subjected to extensive research, especially in malaria endemic areas. In Thailand, PfMSP-119 sequences have been
derived from a single parasite population in Tak province, located along the Thailand-Myanmar border, since 1995.
However, the extent of sequence variation and the spatiotemporal patterns of the MSP-119 haplotypes along the
Thai borders with Laos and Cambodia are unknown.
Methods: Sixty-three isolates of P. falciparum from five geographically isolated populations along the Thai borders
with Myanmar, Laos and Cambodia in three transmission seasons between 2002 and 2008 were collected and
culture-adapted. The msp-1 gene block 17 was sequenced and analysed for the allelic diversity, frequency and
distribution patterns of PfMSP-119 haplotypes in individual populations. The PfMSP-119 haplotype patterns were
then compared between parasite populations to infer the population structure and genetic differentiation of the
malaria parasite.
Results: Five conserved polymorphic positions, which accounted for five distinct haplotypes, of PfMSP-119 were
identified. Differences in the prevalence of PfMSP-119 haplotypes were detected in different geographical regions,
with the highest levels of genetic diversity being found in the Kanchanaburi and Ranong provinces along the
Thailand-Myanmar border and Trat province located at the Thailand-Cambodia border. Despite this variability, the
distribution patterns of individual PfMSP-119 haplotypes seemed to be very similar across the country and over the
three malarial transmission seasons, suggesting that gene flow may operate between parasite populations circulating
in Thailand and the three neighboring countries.
Conclusion: The major MSP-119 haplotypes of P. falciparum populations in all endemic populations during three
transmission seasons in Thailand were identified, providing basic information on the common haplotypes of MSP-119
that is of use for malaria vaccine development and inferring the population structure of P. falciparum populations in
Thailand.
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Because the clinical symptoms and pathology of malarial
infections are caused by the erythrocytic stage cycles of
the Plasmodium parasites [1-3], the development of a
malaria vaccine targeting the asexual blood stage has a
high priority in current malaria research. Safe and effective
malaria vaccines are greatly needed in malaria endemic
areas and could be used to supplement strategies of vector
control and medical treatment for reducing the rates of
morbidity and mortality [4]. The estimated number of
malaria cases in 2012 was over 200 million with about
660,000 deaths [5], mostly in children under five years of
age and pregnant women with heavy exposure to malaria
infections. These numbers are, however, expected to
increase due to treatment failure and/or delay in parasite
clearance associated with the evolution and spread of
drug-resistant malaria parasites [6]. To date, a small
number of vaccines against the blood stage malaria
parasites have been developed and a few of these are
currently undergoing large-scale clinical trials [7,8]. Des-
pite the fact that the majority of the vaccines have been
shown to be safe and highly effective in animal models,
immunizations with these blood stage malaria vaccines in
humans was found to elicit allelic-specific anti-parasitic
immunity [9-11], thereby compromising the efficacy of
these vaccines. This is due to the allelic diversity of the
strongly antigenic portions used as candidate vaccine
antigens in the natural parasite populations, which poses
one of the major challenges to development of effective
vaccines. Thus, it is essential to investigate the extent of
the genetic variation of malarial antigens and the popu-
lation structure of malaria parasites in nature so that a
better malaria vaccine, such as those that incorporate
multiple variants of protective antigens can be properly
designed. Alternatively, the development of malaria vac-
cines based on the conserved epitopes of antigens, if they
are sufficiently antigenic and so elicit protective immunity,
would offer an alternative strategy.
Components of blood stage malaria vaccines are gen-
erally derived from parasite ligands (antigens) expressed
on the surface of merozoites, the only extracellular blood
stage parasite. Among them is the merozoite surface
protein-1 (MSP-1) that is currently used as a major
component of anti-blood stage human malaria vaccines
[12,13]. The gene encoding MSP-1 of the human malaria
parasite Plasmodium falciparum spans ~5 kb in size on
chromosome 9 and can be divided into 17 blocks, accord-
ing to the presence or absence of 9 bp repeats and the type
of repeating sequences [14,15]. The nucleotide sequences
of the msp-1 gene are classified into two allelic types: K1
and MAD20, with the exception of the highly polymorphic
block 2 that is represented by at least three allelic types
(K1, MAD20 and RO33) [16]. The MSP-1 protein is ini-
tially synthesized as a 190 kDa or 195 kDa polypeptide[17]. During the beginning of merozoite invasion into
the host’s erythrocyte, the protein undergoes primary
proteolytic cleavage events to generate four fragments of
83 kDa (MSP-183), 30 kDa (MSP-130), 38 kDa (MSP-138)
and 42 kDa (MSP-142) [18,19]. These fragments are held
together as a complex and attached to the parasite’s
surface via a glycosylphosphatidylinositol anchor. At
the point of merozoite invasion, the MSP-142 fragment is
proteolytically processed to form the 33 kDa (MSP-133)
and 19 kDa (MSP-119) fragments [20]. The MSP-119 frag-
ment, containing two epidermal growth factor (EGF)-like
domains, remains attached to the parasite’s surface [21].
Two coding regions of the msp-1 gene (blocks 2 and
17) have been identified to be prime targets of protective
immunity. Previous studies have indicated that natural
clinical immunity against blood malaria infections targets
the N-terminal fragments encoded by block 2 of msp-1
gene in an allelic-type specific manner [22-24]. Naturally
acquired antibodies to the C-terminal MSP-119, encoded
by block 17 of the msp-1 gene, could also inhibit erythro-
cyte invasion by preventing the secondary processing that
released MSP-119 from the rest of the MSP-1 complex
[20,25]. Invasion-inhibiting antibodies against MSP-119
have been detected in the sera from individuals living in
areas that the highly endemic for malaria and were associ-
ated with protection from clinical malaria [26-33]. As
mentioned, a few MSP-119-based vaccines are currently in
Phase I and Phase II clinical trials in humans and so far
have been shown to be safe and immunogenic [34-36].
Polymorphism in the P. falciparum msp-1 gene block
17 sequences has been fairly extensively researched
and they have been classified into at least 10 MSP-119
haplotypes in natural populations of P. falciparum [37-51].
Of these, four major haplotypes (Q/KNG/L, E/KNG/L,
Q/KNG/L and E/TSR/L) have been frequently identified
in multiple malaria endemic regions. Comparisons of the
distribution patterns and frequencies of MSP-119 haplo-
types among different parasite populations revealed that
the populations of P. falciparum are genetically diverse
[46], consistent with the observations based upon the large-
scale genome-wide sequencing-based and microarray-based
genotyping data [52,53]. In addition, PfMSP-119 haplotypes
can also be utilized to infer the population structure of
P. falciparum parasites. A recent study indicated the
subdivision of two P. falciparum populations in China
according to their variations in the distribution patterns
of MSP-119 haplotypes, where the parasite populations
in Yunnan (South China) appeared to be more closely
related to the parasite populations in Southeast Asia
(Thailand and Vietnam) than those in Hainan Island
located on the South China Sea [46]. The shared dis-
tribution pattern of the haplotypes is consistent with
the fact that many reported cases in Yunnan were
imported malaria from border areas, suggesting an
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mainland Indochina [54].
Recently, the emergence of artemisinin resistance in P.
falciparum has been reported in Southeast Asia and has
drawn the global attention to the need for improvement
in malaria intervention [55,56]. After the first report
incidence of artemisinin resistance in P. falciparum at the
Thailand-Cambodian border in 2008 [57], artemisinin re-
sistance has now been reported on the western border of
Thailand close to Myanmar [58]. Because of this spread of
artemisinin resistance, it is of great interest to investigate
the genetic composition and population structure of
Thai P. falciparum isolates at these localities. In Thailand,
much of the current knowledge of the msp-1 sequence
diversity originated from the analyses of a single parasite
population at Mea Sod, Tak province at the Thai-Myanmar
border [38,39,51], but little work has been done to further
elucidate the level of genetic diversity in other regions
of the country, especially where the artemisinin resistant
parasites are likely to spread. To address this issue, a
cross-sectional survey of the allelic diversity of the msp-1
gene block 17 in five geographically isolated populations
of P. falciparum in Thailand was performed in order to
infer the genetic structure of the parasite populations from
the distribution patterns of their MSP-119 haplotypes. The
outcome of this work will shed light on the nature and
genetic relationship within and between malaria popula-
tions and offer a chance to better understand the parasite’s
evolution, which will be important for establishing an
effective strategy for malaria control and intervention.
Methods
Studied areas and preparation of parasites
Field isolates of P. falciparum were collected from five lo-
calities (1-5), each in a different province, close to the bor-
ders of Thailand and three neighbouring countries. These
were (1) Ubon Ratchathani, located at the Thailand-Laos
border, (2) Trat, located at the Thailand-Cambodia border,
and (3–5) Ranong, Kanchanaburi and Mae Hong Son,
located at the Thailand-Myanmar border. The subjects
were confirmed for P. falciparum mono-infection by
microscopic examination of Giemsa-stained blood smears.
The subjects were recruited in three transmission seasons
between: (1) Jun 2002–Oct 2003, (2) Jun 2004–Dec
2005 but also including one subject in 2006 and (3) Jan
2008–Dec 2008 (see Additional file 1). Sixty-three blood
stage malaria samples were adapted to in vitro culture and
maintained at the Malaria Research Unit, Department of
Biology, Faculty of Science, Chulalongkorn University,
Thailand, as described previously [59]. Of these, 44 sam-
ples collected between 2002 and 2006 were previously
genotyped by 12 microsatellite loci and confirmed to be
independent clones [59] (see Additional file 1). In brief,
the blood stage parasites were cultured in RPMI 1640medium containing 25 mM HEPES, 4% (v/v) human
blood group O erythrocytes (4% haematocrit), 10% (v/v)
pooled heat-inactivated serum from healthy donors,
24 mM sodium bicarbonate and 10 μg/mL gentamycin
at 37°C with 5% (v/v) CO2, 5% (v/v) O2 and 90% (v/v) N2.
The medium was changed daily, and the parasites were
allowed to grow to a parasitaemia level of 5-10% and then
harvested prior to genomic DNA preparation.
Preparation of P. falciparum genomic DNA
Procedures for preparation of the blood stage malaria
parasites and genomic DNA were performed as previously
described [60,61]. Briefly, P. falciparum infected blood
samples were centrifuged at 5,000 g and the supernatant
was discarded. Then, a 200 μL volume of the packed blood
cells was mixed with 500 μL of 0.05% (w/v) saponin solu-
tion in phosphate buffered saline (PBS, pH 7.4) to release
the blood stage malaria parasites from the human erythro-
cytes. The parasite pellets were collected by centrifugation
at 10,000 g for 10 min and washed twice in PBS. The
parasites were lysed in a lysis solution (40 mM Tris-HCl,
80 mM EDTA, 2% (w/v) sodium dodecyl sulfate, pH 8.0)
containing 2 mg/mL proteinase K. The suspension was
sequentially treated with an equal volume of phenol
(pH 8.0), phenol/chloroform/isoamyl alcohol (25:24:1
(v/v/v), pH 8.0) and chloroform, harvesting the aqueous
phase each time. The genomic DNA was then recovered
by ethanol precipitation in the presence of 0.3 M sodium
acetate and later dissolved in standard TE buffer (10 mM
Tris-HCl, 1 mM EDTA, pH 8.0) and stored at -20°C prior
to PCR amplification.
Amplification and DNA sequencing of the P. falciparum
msp-1 gene block 17
A DNA fragment corresponding to the msp-1 gene block
17 was amplified by the polymerase chain reaction (PCR)
with the MM1/17F (5′-TCACAACACCAATGCGTAAA
A-3′) and MM1/17R (5′-GAGTATTAATAAGAATGATA
TTCCTAAG-3′) primer pair, which correspond to nu-
cleotide positions 4,825–4,845 and 5,136–5,109 of the
coding sequence of the msp-1 gene of the P. falciparum
strain 3D7 (NCBI accession number: XM_001352134,
[62]). The PCR amplification reactions were performed
in a 50 μL volume containing 200–300 ng of DNA tem-
plate, 2 mM of MgCl2, 200 μM of each dNTP, 0.5 μM
each of the forward and reverse primers and 2 units (U) of
iTaq™-DNA polymerase enzyme in 1X iTaq PCR buffer
(iNtRON Biotechnology, Republic of Korea). Thermal cyc-
ling was performed with an optimized profile of an initial
denaturation at 95°C for 5 min, followed by 30 cycles
of 95°C for 40 s, 53°C for 40 s and 72°C for 40 s, and
subsequently a final extension at 72°C for 5 min. PCR
products were analysed by standard gel electrophoresis,
stained with ethidium bromide and visualized by UV
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cons with an expected size of 220 bp, and were subjected
to direct Sanger DNA sequencing in both the forward and
reverse directions to ensure the accuracy of obtained
sequences. Sequencing reactions were performed using
the BigDye Terminator v1.1 kit (Applied Biosystems,
USA) with an ABI3730 DNA analyser. DNA sequences
were manually edited using Bioedit 7.0.0 software and
aligned using the MUSCLE Sequence Alignment algo-
rithm in the MEGA 5.2 program [63]. In total, 61 DNA
samples generated unambiguous sequences in both di-
rections and were used in the subsequent population
genetic analysis.
DNA sequence analysis and statistical analysis
The predicted amino acid sequences of the C-terminal
fragment of PfMSP-119 from the PCR sequenced genomic
fragments were aligned with the corresponding sequence
of the P. falciparum genome reference strain 3D7 using
the MUSCLE Sequence Alignment algorithms as above.
The extent of genetic diversity was estimated by the
number and ratio of MSP-119 haplotypes prevalent in
the populations. Divergences in the distribution pattern of
PfMSP-119 haplotypes between two parasite populations
was tested for using the Wright’s fixation index (Fst) with
Arlequin suite version 3.5 [64]. In addition, the departure
from the predictions of the neutral mode of molecular
evolution was evaluated using three neutrality tests
(Tajima’s D, Fu & Li’s D*and Fu & Li’s F*indices) imple-
ment in the DnaSP 5.1 program [65]. Results were deemed
to be statistically significant if the p value was less than
0.05 (p < 0.05).
Results
Sequence diversity of msp-1 gene block 17
Nucleotide sequences of P. falciparum msp-1 gene block
17 (corresponding to nucleotide positions 4990 to 5208
after Tanabe et al. [15]) encoding the C-terminal fragment
of the MSP-1 protein (MSP-119, amino acid positions
1644 to 1716 after Miller et al. [14]) were obtained from
61 parasite isolates from five geographical locations in
Thailand between 2002 and 2008, as described in the
Materials and Methods. Five polymorphic sites (2.28%
of the 219 nt. fragments analysed) at nucleotide positions
4990 G/C, 5132 C/A, 5159 G/A, 5161 G/A and 5206 C/T
were detected (see Additional file 2 for the sequence align-
ment). The nucleotide substitution frequency at positions
4990, 5132, 5159, 5161 and 5206 was G/C (43/18;70.5/
29.5%), C/A (10/51; 16.4/83.6%), G/A (51/10; 83.6/16.4%),
G/A (55/6; 90.2/9.8%) and C/T (58/3; 95/5%), respectively.
These nucleotide substitutions results in non-synonmous
amino acid substitutions at positions 1644 E (GAA)/ Q
(CAA), 1691 T (ACA)/K (AAA), 1700 S (AGC)/N (AAC),
1701 G (GGA)/ R (AGA) and 1716 L (CTT)/ F (TTT)(the italicized letter indicated the polymorphic site). The
frequency of amino acid substitutions at each site was
E1664Q (43/18; 70/30%), T1691K (10/51; 16/84%),
S1700N (10/51; 16/84%), R1701G (6/55; 10/90%) and
L1716F (58/3; 95/5%). The PfMSP-119 fragment contained
nine conserved Cys residues. The first amino acid substi-
tution (E1664Q) was located between the second and
the third Cys residues in the first putative EGF-like
motif, while the other substitutions occurred in the
second EGF-like motif of PfMSP-119 (Figure 1). Therefore,
the PfMSP-119 amino acid sequences yielded five distinct
haplotypes: E/KNG/L, E/TSR/L, Q/KNG/L, E/TSG/L
(3D7 type) and Q/KNG/F, all of which have been reported
previously [37-51].
Prevalence and distribution patterns of MSP-119 in
geographically isolated Thai P. falciparum populations
Figure 2 shows the overall prevalence and distribution
pattern of PfMSP-119 haplotypes in the five geographical
locations of Mae Hong Son (n = 9), Kanchanaburi (n = 15)
and Ranong (n = 14), located at the Thailand-Myanmar
border, Ubon Ratchathani (n = 12) located at the Thailand-
Laos border, and Trat (n = 11), located at the Thailand-
Cambodia border (see also Additional file 1). Of the five
haplotypes identified, E/KNG/L, Q/KNG/L and E/TSR/L
were the most prevalent and were found in all sampled
sites, representing 57%, 23% and 11% of the overall haplo-
types investigated, respectively.
These results also revealed that there were slight dif-
ferences in the levels of genetic diversity, based upon
the number of PfMSP-119 haplotypes, among the differ-
ent geographical populations (Figure 2). P. falciparum
populations in Mae Hong Son and Ubon Ratchathani
were the least genetically diverse group of parasites, with
only three haplotypes identified. E/KNG/L was the major
PfMSP-119 haplotype at both sites, and represented
75–78% of the total haplotypes. In contrast, all the five
PfMSP-119 haplotypes were prevalent in the other three P.
falciparum populations. Only in Trat was four haplotypes
(all except for haplotype Q/KNG/F) identified. In these
three sites, the E/KNG/L, Q/KNG/L and E/TSR/L haplo-
types constituted more than 80% of the total haplotypes
investigated. Thus, the level of genetic diversity varied
according to the geographical location of the parasite
populations, which might reflect variation in the trans-
mission intensity and multiplicity of human malaria
infections between sampling sites [66].
To further determine whether the geographically isolated
parasite populations are genetically isolated, pair-wise inter-
population comparisons were performed for each parasite
population using the Wright’s fixation index (Fst). In this
test, the distribution patterns of PfMSP-119 haplotypes in
Tak province (collected in 1995), which is located between
Kanchanaburi (the region in which the parasite genetic
Figure 1 Haplotypes of the C-terminal fragment of merozoite surface protein-1 (PfMSP-119) from Plasmodium falciparum populations
in Thailand. The arrows indicate the epidermal growth factor (EGF)-like domains 1 and 2 [21]. Asterisks (*) indicate the non-synonymous amino
acid substitutions. Numbers above the MSP-1 amino acid sequence of the P. falciparum 3D7 indicated the positions after Miller et al. [14]. Dashes
(-) represent identical amino acid sequences. Number in bracket indicates the number of parasite isolates with that specific PfMSP-119 haplotype.
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which the parasite genetic diversity was lowest), from two
previous studies were also included. One consisted of 8
E/TSR/L, 25 E/KNG/L, 12 Q/KNG/L and 3 Q/KNG/F
haplotypes (total = 48) [39], while the other comprised
14 E/TSR/L, 39 E/KNG/L, 13 Q/KNG/L, 4 Q/KNG/F
and 2 E/TSG/L haplotypes (total = 72) [38]. As shownFigure 2 Allelic diversity of the C-terminal fragment of PfMSP-119 in P
were at the borders of Thailand and three neighboring countries: Ubon Ra
the Cambodian-Thailand border, and Mae Hong Son (M), Kanchanaburi (K)
of the total parasite isolates in Thailand (overall) or the parasites from each
the percentage of each MSP-119 haplotype (E/KNG/L, dark blue; Q/KNG/L, rin Table 1, the Fst values from the pairs of all the six
parasite populations were low and non-significant (p > 0.05).
Accordingly, the P. falciparum parasite populations (or
at least the PfMSP-119) circulating in this region are
genetically homogeneous, suggesting gene flow between
allopatric populations of the malaria parasites near the
borders of Thailand with Myanmar, Laos and Cambodia.lasmodium falciparum populations in Thailand. Sampling sites
tchathani (U), located at the Laos-Thailand border, Trat (T), located at
and Ranong (R), located at the Myanmar-Thailand border. Numbers (n)
locality are displayed in the bracket. Numbers in pie charts represent
ed; E/TSR/L, green; E/TSG/L, purple; QKNG/F, light blue).
Table 1 Pairwise Fst values of PfMSP-119 haplotypes between geographically isolated Plasmodium falciparum
populations in Thailand
Mae Hong Son Ubon Ratchathani Kanchanaburi Trat Ranong
Ubon Ratchathani -0.09985 -
(p = 0.99)
Kanchanaburi -0.04761 -0.02984 -
(p = 0.77) (p = 0.56)
Trat -0.01113 0.01017 -0.05754 -
(p = 0.41) (p = 0.23) (p = 0.73)
Ranong 0.00241 -0.00344 -0.04347 -0.04642 -
(p = 0.42) (p = 0.39) (p = 0.72) (p = 0.74)
Tak* -0.02637 -0.01682 -0.03795 -0.03720 -0.02997
(p = 0.51) (p = 0.55) (p = 0.89) (p = 0.67) (p = 0.71)
Tak** -0.02075 -0.00632 -0.02612 -0.01521 -0.0010
(p = 0.4 (p = 0.46) (p = 0.89) (p = 0.66) (p = 0.71)
Frequency of the PfMSP-119 haplotypes in Tak were derived from two studies by (*) Sakihama et al., [38] and (**) Sakihama et al., [39]. All Fst values were
non-significant (p > 0.05).
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transmission seasons
The prevalence of MSP-119 haplotypes in three trans-
mission seasons is shown in Figure 3. Of the 61 msp-1
sequences analysed, 21 sequences were obtained in a
15-month period between Jun 2002–Oct 2003 and con-
tained three haplotypes (E/KNG/L, E/TSR/L and Q/
KNG/L); 25 sequences were obtained in an 18-month
period between Jun 2004–Dec 2005 (plus one sample
collected in early 2006) and contained all five haplotypes;
and 15 sequences were collected in a 12-month period be-
tween Jan–Dec 2008. As seen in Figure 3, the E/KNG/L
and Q/KNG/L haplotypes were the two most prevalent
haplotypes in all three seasons, with cumulative frequencies
of 60–80% of the haplotypes identified throughout theFigure 3 Prevalence of the C-terminal fragments of PfMSP-119 in
Thai Plasmodium falciparum populations over time. P. falciparum
samples were collected in three transmission seasons: Jun 2002–Oct
2003, Jun 2004–Dec 2005 (but including one sample collected in 2006,
see Materials and Methods) and Jan 2008–Dec 20008. MSP-119
haplotypes: E/KNG/L, blue; Q/KNG/L, green; E/TSR/L, black; E/TSG/L, red;
Q/KNG/F, yellow.study years. However, over this time period the E/KNG/L
haplotype decreased in frequency whilst the Q/KNG/L
haplotype increased, with the relative E/KNG/L: Q/KNG/L
proportion changing from 3.5:1 in Jun 2002–Oct 2003 to
1:1 in Jan 2008–Dec 2008, indicating longitudinal variation
in the frequencies of the prevalent haplotypes. In contrast,
the frequencies of each of the three minor haplotypes
remained low (>10%) and relatively stable throughout the
three-year period.
Pair-wise inter-population comparison of the PfMSP-119
haplotypes between years was compared using the Wright’s
fixation index (Fst), and this revealed low and non-
significant Fst values (p > 0.05) (Table 2), suggesting a
similar MSP-119 haplotype distribution between the para-
site populations in successive years. Furthermore, when
the haplotypes of MSP-119 from Tak province (collected
in 1995 [38,39]) was included in the analysis, the results
also revealed a similar haplotype distribution in 1995 and
the other study periods (see Table 2). Thus, the frequen-
cies of the individual haplotypes were potentially stable
during the four transmission seasons.
Selection signature on msp-1 gene block 17 locus
The geographically separate and so potentially isolated
populations of P. falciparum in Thailand were found to
not be significantly heterogeneous at the PfMSP-119 locus,
suggesting that the different PfMSP-119 haplotypes may
be maintained by balancing selection. Therefore, intra-
population based analyses (Tajima’s D test, Fu & Li’s D* test
and Fu & Li’s F* test) were used to evaluate the selection
signature on the PfMSP-119 locus. No significant positive D
value (Tajima’D= 0.4082; Fu & Li’s D* = 1.079 and Fu & Li’s
F* = 1.016) was found for the entire block 17 coding region.
In addition, although a sliding window analyses of Tajima’s
Table 2 Pairwise Fst values of PfMSP-119 haplotypes in Plasmodium falciparum populations in the sampling years 1995,
2002-2003, 2004-2005 and 2008
Population in 1995* Population in 1995** Population in Jun 02-Oct 03 Population in Jun 04-Dec 05
Population in Jun 02-Oct 03 0.00575 -0.00694 *
(p = 0.30) (p = 0.40)
Population in Jun 04-Dec 05 -0.00268 -0.01639 -0.02722 *
(p = 0.92) (p = 0.71) (p = 0.73)
Population in Jan 08-Dec 08 0.02685 -0.02287 0.04219 0.00518
(p = 0.16) (p = 0.59) (p = 0.14) (p = 0.30)
Frequency of the PfMSP-119 haplotypes in 1995 were from two studies by (*) Sakihama et al., [38] and (**) Sakihama et al., [39]. All Fst values were non-significant (p> 0.05).
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tive D values for the EGF-1 and EGF-2 domains, they were
not statistically significant (Figure 4). A comparison of
the ratio of synonymous to non-synonymous substitutions
(Ka/Ks) was not analysed because the number of synonym-
ous differences (Ks) was too low (zero). Overall, the poly-
morphisms at the C-terminal fragment of the msp-1 gene
block 17 were less likely to be under strong immune selec-
tion, suggesting a functional constraint that limits the allelic
diversity of the sequences. Taken together, the polymor-
phisms detected in PfMSP-119 were neutral and highly
conserved in the geographically isolated, but genetically
homogenous P. falciparum populations in Thailand.
Discussion
The 19-kDa antigenic domain of PfMSP-1 is considered the
major target component for the developmetn of human
blood stage malaria vaccines [13]. Therefore, the analysis
of the sequence diversity of the msp-1 gene block 17 that
encodes PfMSP-119 has gained considerable attention in
the global malaria research community, leading to the
identification of its polymorphism level and haplotypes
[37-51]. PfMSP-119 sequences have been primarily classi-
fied into two prototypic allelic groups: (1) the MAD20
prototypic allelic group (E/TSR/L haplotype) and (2) the
Wellcome prototype allelic group (Q/KNG/L haplotype)
[15]. In addition, other variant haplotypes (E/KNG/L,
E/TSG/L and Q/KNG/F) have also been reported in naturalFigure 4 Sliding window plots of Tajima’s D, Fu & Li’s D* and Fu & Li’
step size is 3 bp. No evidence of a significant departure from neutrality orpopulations of P. falciparum worldwide [37-51]. These
haplotypes were proposed to be generated through recom-
bination events between the two prototype alleles and due
to mutations [42]. The analysis of PfMSP-119 sequence
diversity in Thailand was previously conducted in a single
locality in Tak, located on the western border of Thailand
and identified at least five distinct haplotypes (E/KNG/L,
E/TSR/L, Q/KNG/L, E/TSG/L and Q/KNG/F) [38]. How-
ever, it is not known whether the extent of PfMSP-119
sequence variation is common in other populations of P.
falciparum in Thailand or whether the distribution pat-
tern of these haplotypes is conserved. This question
formed the basis of the present study, which aimed to
screen for polymorphism and evaluate the haplotypes
of the msp-1 gene block 17 from different geographical
regions in Thailand.
Nucleotide sequence analysis of the msp-1 gene block
17 was performed on 61 Thai P. falciparum isolates
originating from five endemic areas; Mea Hong Son,
Kanchanaburi and Ranong, along the borders of Thailand
and Myanmar, Trat at the border of Thailand and
Cambodia, and Ubon Ratchathani, at the border of Thailand
and Laos. These areas were among the top 15 provinces
with the highest numbers of P. falciparum malaria cases
in Thailand [67]. The five conserved polymorphic SNP
sites that caused non-synonymous amino acid substitu-
tions in the PfMSP-119 sequences (haplotypes E/KNG/L,
E/TSR/L, Q/KNG/L, E/TSG/L and Q/KNG/F) previouslys F* for the Pfmsp-1 gene block 17. Window length is 90 bp and
of diversifying selection was observed.
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worldwide [37,40-50], were found with no new haplotypes.
Consistent with previous observations, these results re-
ported here indicated that the allelic diversity of the msp-1
gene block 17 in Thai P. falciparum populations was
limited.
The levels of genetic diversity of the msp-1 sequences
in Thai populations varied according to the geographical
locations. The lowest genetic diversity was detected in P.
falciparum populations in Mae Hong Son and Ubon
Ratchathani, with only three PfMSP-119 haplotypes of be-
ing found, compared to four and five in Kanchanaburi and
Ranong, respectively. Variation in the levels of genetic
diversity in geographically isolated populations may be
due to variation in the multiplicity of infection, malaria
incidence, transmission intensity and levels of gene flow
between the parasite populations [59,66]. Malaria inci-
dence rates showed a high spatial heterogeneity across the
geographical regions in Thailand, with the highest rates in
the regions near the borders of Thailand with Myanmar
and Cambodia and lower rates in the regions near the
Thailand-Laos border [68]. In addition, multiple or poly-
clonal infections with P. falciparum were highly prevalent
at the Thailand-Myanmar border region in Kanchanaburi
compared to at the Thailand-Laos borders [59]. Elevated
levels of mixed genotype infections may well increase the
frequency of recombination events of the msp-1 alleles in
the mosquito and subsequently a high diversity of msp-1
would be maintained in Thai populations [66].
When the diversity and distribution patterns of MSP-119
haplotypes in Thai populations in the present study were
compared with results from a previous study based upon
microsatellite typing [59], no genetic differentiations was
found between sub-populations in Mae Hong Son and
Ubon Ratchathani, Mae Hong Son and Trat, Mae Hong
Son and Ranong, Kanchanaburi and Ranong, and Ubon
Ratchathani and Trat. However, the microsatellite analysis
revealed a significant level of differentiation between sub-
populations in Kanchanaburi and three other provinces
(Mae Hong Son, Ubon Ratchathani and Trat), and in
Ranong and two other provinces (Ubon Ratchathani and
Trat). The discrepancy could be partly attributed to the
differences in the sample size and the types of genetic
markers used. Whether genetic differentiations exist in
Thai sub-populations will require further investigations
using a larger size of samples and additional markers, and
this is an area of our current research.
The level of genetic differentiation of PfMSP-119 in
populations in Thailand, as detected using F-statistics
(Fst), revealed no significant differences between the P.
falciparum populations located at the Thai borders with
Myanmar, Laos and Cambodia. Accordingly, there may
be no barriers that limit gene flow between geographically
isolated P. falciparum populations in Thailand. This wouldlikely reflect that there are numerous host (human) move-
ments within and into Thailand from neighboring countries
from immigrants who live across the borders [69,70]. For
example, it was reported that in 2006 there were 30,338
malaria cases found in native Thais compared to 36,313
malaria cases from foreigners living in Thailand [71]. A
cross-sectional survey showed that up to 75% of the malaria
incidences in regions along the Thai borders were imported
cases [67]. The majority of malaria-infected migrant workers
were from Cambodia, Myanmar and Laos. Short-term and
permanent migrations of infected humans, such as immi-
grant workers, may play a key role in the development
and spread of anti-malaria drug resistance. This study also
indicated that the Thai parasite populations along the
three national borders are not genetically separated (and
so may be mixed) and so are potentially subject to gene
flow of novel phenotypes, most probably from Myanmar
and Cambodia, where malaria transmission rates are high
and multiclonal infections are prevalent. Gene flow within
parasite populations may play an important role in shap-
ing their population structure. Indeed, previous studies
showed that the emergence of artemisinin resistance
in P. falciparum occurred around the Thai-Cambodia
border in 2009 and now has recently been found at the
Thai-Myanmar border in 2011. The results from this
study suggest that it is likely that the artemisinin resistant
strains of P. falciparum could also spread to other regions
of Thailand.
The longitudinal survey of MSP-119 haplotypes in four
transmission seasons (from 1995 to 2008) revealed that
the overall frequency of individual PfMSP-119 haplo-
types was relatively stable, although the two major hap-
lotypes (E/KNG/L and Q/KNG/L) inversely fluctuated
over time. This result was also seen in a previous longitu-
dinal survey in Mali [44]. Comparison of the frequency of
these PfMSP-119 haplotypes in endemic regions worldwide
indicated a dramatic distribution pattern and frequency
of PfMSP-119 haplotypes. The high prevalence of the
E/KNG/L and Q/KNG/L haplotypes reported in Thailand
has also been reported in the Yunan and Hainan provinces
in China and Vietnam [37,46], suggesting that P. falcip-
arum populations in the Greater Mekong Sub-region
(GMS) (China, Thailand, Laos, Myanmar, Cambodia and
Vietnam) could be genetically related. Whether the para-
site populations in GMS are genetically homogeneous will
need to be evaluated by large-scale genotyping approaches
using genome-wide genetic markers (e.g. microsatel-
lites and SNPs, see [72]). Similar distribution patterns
of PfMSP-119 in samples from the GMS have also been
detected in African countries, such as Kenya, Tanzania
and Mali [42-44]. In contrast, the three rare PfMSP-119
haplotypes (E/TSR/L, ETSG/L and Q/KNG/L) appeared
to be the dominant haplotypes in other regions, such
as South Asia (India and Iran), South America (Brazil
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By providing information about the prevalence and
spatiotemporal dynamics of PfMSP-119 haplotypes, this
study could help inform choices about which PfMSP-119
haplotypes to formulate future vaccines from and to allow
a more accurate interpretation of the efficacy of current
formulations of PfMSP-119 based vaccines being tested in
clinical trials. Currently, MSP-1 sequences from P. falcip-
arum K1 (Q/KNG/L) are being formulated as components
of the multivalent blood stage vaccine PfCP-2.9 [35]. If the
immunity conferred by such vaccines is allele specific, the
PfCP-2.9 vaccine would be advantageous for populations
in the GMS and in Africa, but not in South America and
the Asian Pacific Islands.
It is possible that the limited allelic diversity in the
MSP-119 sequences may be due to positive selection or
balancing selection, as has been demonstrated for other
regions of MSP-1 [22]. However, the Tajima’s D test, Fu &
Li’s D* test and Fu & Li’s F* test all failed to reveal any sta-
tistically significant evidence for strong positive or balan-
cing selection of the C-terminal fragments of PfMSP-119 in
these Thai samples. The most probable explanation for the
limited diversity in PfMSP-119 is the functional constraint
of the protein. MSP-1 is considered to play an important
role in erythrocyte entry by the merozoite [13]. Secondary
processing of PfMSP-1 to PfMSP-119 is a prerequisite for
merozoite invasion [73]. The PfMSP-119 fragment possesses
different epitopes and variation in the motifs alters the con-
formational structure markedly [74,75]. It may be that each
motif has a unique association with other parts of MSP-1
and these differential intermolecular associations have
implications in evading the host immune responses by
masking the target epitopes in the 19-kDa domain [76].
Thus, selective constraints in the light of the host immune
responses and functional constraints at the protein level
may be co-operative to maintain the limited diversity of
the MSP-119 amino acid sequences.Conclusion
This study extends the understanding and current know-
ledge of the variation and prevalence of PfMSP-119 poly-
morphisms in natural populations of P. falciparum in
Thailand. The data supports the view that P. falciparum
populations in the GMS region are genetically diverse.
Analysis of the spatiotemporal patterns of MSP-1 haplotypes
indicated that E/KNG/L and Q/KNG/L were the major
haplotypes in Thailand, which were also highly prevalent
in populations from other Southeast Asian countries,
China and Africa. This study provides the basis for the ac-
curate measurement and interpretation of the population
structure and dynamics of malaria parasites that is critical
for monitoring the population responses to MSP-1 based
vaccines in clinical trials.Additional files
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